Baldwin Brothers LLC Renalytix PLC Transaction History

Baldwin Brothers LLC

  • $1.43 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021
SELL
$17.91 - $34.78 $17,910 - $34,780
-1,000 Closed
0 $0
Q1 2021

Apr 08, 2021
BUY
$15.25 - $31.13 $15,250 - $31,130
1,000 New
1,000 $26,000

Others Institutions Holding RNLX

# of Institutions
29
Shares Held
3.88M
Call Options Held
13.7K
Put Options Held
0
View Full List

About Renalytix plc

RNLX Quotes by TradingView
  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email